BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1365 related articles for article (PubMed ID: 32422009)

  • 1. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
    Cao D; Wang Y; Li D; Wang L
    Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer.
    Fan Q; Liu B
    Onco Targets Ther; 2018; 11():2453-2466. PubMed ID: 29760555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
    Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
    J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
    Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
    J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.
    Zhang F; Zeng L; Cai Q; Xu Z; Liu R; Zhong H; Mukiibi R; Deng L; Tang X; Xin H
    Cancer Control; 2020; 27(2):1073274820936991. PubMed ID: 32597194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six long noncoding RNAs as potentially biomarkers involved in competitive endogenous RNA of hepatocellular carcinoma.
    Qu L; Cai X; Xu J; Wei X; Qu X; Sun L; Gong L; Su C; Zhu Y
    Clin Exp Med; 2020 Aug; 20(3):437-447. PubMed ID: 32514710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.
    Jing Z; Guo S; Zhang P; Liang Z
    Technol Cancer Res Treat; 2020; 19():1533033820985787. PubMed ID: 33371795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis.
    Sun X; Ge X; Xu Z; Chen D
    J Gastroenterol Hepatol; 2020 Jan; 35(1):157-164. PubMed ID: 31222831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of key genes, microRNAs and long non-coding RNAs in hepatocellular carcinoma.
    Shi B; Zhang X; Chao L; Zheng Y; Tan Y; Wang L; Zhang W
    FEBS Open Bio; 2018 Sep; 8(9):1424-1436. PubMed ID: 30186744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of differentially expressed Her-2 related lncRNA-mRNA-miRNA ceRNA network in Her-2 positive breast cancer.
    Jia X; Meng W; Zhang L; Jia Y; Shi Y; Tong Z
    Transl Cancer Res; 2020 Apr; 9(4):2527-2533. PubMed ID: 35117612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
    Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
    Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing endogenous RNA network and prognostic nomograms for hepatocellular carcinoma patients who underwent R0 resection.
    Li Y; Ma B; Yin Z; Liu P; Liu J; Li J; Wang F; Chen H
    J Cell Physiol; 2019 Nov; 234(11):20342-20353. PubMed ID: 30963571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and Comprehensive Analyses of a Competing Endogenous RNA Network in Tumor-Node-Metastasis Stage I Hepatocellular Carcinoma.
    Gu X; Li H; Sha L; Zhao W
    Biomed Res Int; 2020; 2020():5831064. PubMed ID: 32104698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.